Question 1

What is DRAP and why is it important for medical device manufacturers?

Accepted Answer

The Drug Regulatory Authority of Pakistan (DRAP) is Pakistan's national regulatory body responsible for pharmaceuticals and medical devices under the Ministry of National Health Services, Regulations and Coordination. DRAP enforces the Medical Device Rules 2017 (MDR 2017), which established a comprehensive regulatory framework for medical devices in Pakistan. All medical devices marketed in Pakistan require registration with DRAP, and foreign manufacturers must designate a Pakistani agent and obtain Import Registration Certificates (IRC). DRAP is modernizing regulations to align with international standards and enhance patient safety.

Question 2

What are the Medical Device Rules 2017 (MDR 2017) in Pakistan?

Accepted Answer

The Medical Device Rules 2017 (MDR 2017) established Pakistan's first comprehensive regulatory framework for medical devices. Key Provisions: Risk-based classification system (Class A, B, C, D), mandatory device registration with DRAP before commercialization, quality management system requirements (ISO 13485 or equivalent), Pakistani agent designation for foreign manufacturers, import registration certificate (IRC) requirements, post-market surveillance and adverse event reporting, labeling and information requirements. Implementation: Phased implementation with ongoing guidance development, gradual enforcement as DRAP builds capacity, manufacturers should proactively comply to avoid market access issues. MDR 2017 aligns Pakistan with international best practices and improves device quality and safety oversight.

Question 3

How does Pakistan classify medical devices?

Accepted Answer

Pakistan uses a risk-based classification system under MDR 2017: Class A: Low risk (e.g., non-invasive devices, general medical equipment), simplified registration with basic documentation, Class B: Low-medium risk (e.g., short-term invasive, channeling devices), moderate registration requirements, Class C: Medium-high risk (e.g., long-term invasive, active therapeutic devices), more extensive technical documentation required, Class D: High risk (e.g., implantable, life-sustaining, drug-device combinations), most stringent registration requirements including clinical data. Classification is based on: invasiveness, duration of body contact, whether device is active, intended purpose and critical therapeutic nature, interaction with circulatory system or medications. Higher class devices face longer review timelines and more rigorous evaluation.

Question 4

What is a Pakistani Agent and what are their responsibilities?

Accepted Answer

A Pakistani Agent (also called Authorized Representative or Local Agent) is a person or legal entity domiciled in Pakistan designated by a foreign manufacturer to act as their regulatory representative with DRAP. Requirements: Must be domiciled in Pakistan with valid business registration, registered with DRAP for the specific manufacturer and device(s), Responsibilities: Submit device registration applications to DRAP, maintain technical documentation and quality certificates, serve as liaison between foreign manufacturer and DRAP, handle post-market surveillance and adverse event reporting, coordinate product recalls and corrective actions, obtain and maintain Import Registration Certificates (IRC), ensure compliance with Pakistani labeling and regulatory requirements. A Pakistani Agent is mandatory for all foreign manufacturers seeking to market devices in Pakistan. Many manufacturers engage Pakistani distributors or regulatory consultants as their agents.

Question 5

What are the device registration requirements in Pakistan?

Accepted Answer

Registration Application to DRAP: Device classification (Class A-D per MDR 2017), Pakistani agent designation, manufacturer quality certificate (ISO 13485 or equivalent), free sale certificate from country of origin, conformity certificate (CE marking, FDA approval, etc.), technical documentation (device description, intended use, specifications, labeling, instructions for use), Import Registration Certificate (IRC): Separate certificate required for importing devices, issued to Pakistani agent/importer, based on DRAP device registration. Processing Timelines: Class A/B: 3-6 months, Class C/D: 6-12 months, timelines depend on completeness of application and DRAP workload. Validity: Registration typically valid for 3-5 years (renewable), IRC must be renewed annually or biennially. Foreign manufacturers should work closely with Pakistani agents to navigate registration process and maintain compliance.

Question 6

What quality and conformity certificates does DRAP accept?

Accepted Answer

DRAP requires manufacturers to demonstrate quality management and device conformity for registration under MDR 2017. Quality Certificates (Manufacturer): ISO 13485 certification (preferred and most widely accepted), CE marking certificate (indicates ISO 13485 compliance), FDA establishment registration, WHO-GMP certificate, other internationally recognized QMS certificates. Conformity Certificates (Device): CE marking from EU Notified Body, FDA 510(k) clearance or PMA approval, TGA (Australia), Health Canada license, other recognized regulatory approvals, free sale certificate from country of origin (mandatory). Certificate Requirements: Must be current and valid, issued by accredited certification body or recognized regulator, cover the specific manufacturing site(s) and device models. International certificates streamline DRAP review and demonstrate global acceptance. ISO 13485 is strongly recommended as the foundational quality certificate for Pakistani market access.

Question 7

How often is Pakistan DRAP regulatory news updated and how can I stay informed?

Accepted Answer

DRAP regularly publishes notifications, guidance documents, and regulatory updates related to MDR 2017 implementation, device registration procedures, and post-market requirements. Recent focus includes capacity building, digitalization of registration processes, and enhanced enforcement. Our platform aggregates daily updates from 7 premium commercial sources including RAPS, Emergo by UL, and Citeline. We recommend checking this page regularly and working closely with your Pakistani agent to monitor DRAP announcements, as the regulatory landscape continues to evolve with MDR 2017 implementation.

Question 8

What commercial sources does this platform use for Pakistan news?

Accepted Answer

We aggregate Pakistani regulatory intelligence from 7 premium sources: RAPS (Regulatory Affairs Professionals Society), Emergo by UL, Citeline MedTech Insight, Pacific Bridge Medical, Asia Actual, Pure Global's proprietary research, and Qualtechs. These sources provide expert analysis, real-time updates, and strategic insights beyond basic DRAP announcements, helping you navigate MDR 2017 compliance, device registration, Pakistani agent designation, IRC requirements, and quality certification.

Pakistan DRAP Medical Device News 2026: Registration & Regulatory Updates

About Pakistan DRAP Regulatory News

Frequently Asked Questions About DRAP News